Satisfying needs for

niche Specialty Care products

00 / pharma& news


Continuing to build up our organisation, following the acquisition of Pegasys, pharma& is pleased to welcome Detlef Jakschies, PhD as Medical & Scientific Director. Detlef will be responsible for leading and implementing pharma&’s medical and scientific strategies, developing customized solutions to best serve the patients’ needs, with a focus on our worldwide business for Pegasys (Peginterferon alfa 2a).


Detlef joins us with a strong background in the field of Interferons, ranging from research at the Medical School of Hannover to various commercial roles in the pharmaceutical industry over the last 20 years, focussing on scientific leadership in the field of haematology and oncology. Respected and valued for his deep scientific understanding and clinical know-how, he is regarded as a valuable partner for his customers and peers alike and has established a strong network within the scientific community.

more news /

01 / pharma& is

pharma& is a privately owned company, aiming at satisfying needs for niche, original, Specialty Care products.

Our commitment to patient access for well-established original Specialty Care medicines and our worldwide presence of own subsidiaries, affiliated companies and partnerships, secure sustainable product availibilty in markets around the world.

02 / pharma& story

After having acquired multiple products in various therapeutic areas and having established a profound base to secure patient access and to supply products across the entire European Landscape we have expanded our footprint to serve patients around the world.

We are proud of our “every patient counts” commitment and our strong partnership network.

03 / pharma& team

All of us have been trained over decades in Top Tier Global Pharmaceutical Companies, coming together as a team, committed and enjoying to grow together.


Supported by our trusted network of highly qualified service providers and experts, we want to shape our future and to leave footprints for the benefits of our patients, their caregivers and our stakeholders.

04 / pharma& founders

Frank Rotmann

  • Grey LinkedIn Icon

" Throughout my 20+ years

in the industry, I have developed a track record in building

and developing organisations

for growth! "

Elmar Zagler

  • Grey LinkedIn Icon

" Having started my career in Finance, I know how to optimize businesses and

how to leverage

networks & alliances! "

05 / pharma& portfolio
05.1 / prescription medicines
05.2 / consumer health
05.3 / affiliated companies

06 / pharma& pharmacovigilance contact


Bei Nebenwirkungen wenden Sie sich bitte an

oder schreiben Sie ein Email an  

Zusätzlich können Sie auch direkt über die Homepage des Bundesamtes für Sicherheit im Gesundheitswesen ( Nebenwirkungsfälle melden.


In case of adverse events, please contact

or send an Email to  

Additionally, you can also report adverse events via your local health authorities.


Voor het melden van bijwerkingen, contacteer

of u kunt een e-mail sturen naar

Daarnaast kunt u bijwerkingen ook melden bij het Lareb,


zr pharma& GmbH

Rauhensteingasse 10/14

1010 Vienna


  • LinkedIn - White Circle


pharma& Schweiz GmbH

Poststrasse 30

6300 Zug


© 2021 by pharma&